首页 | 本学科首页   官方微博 | 高级检索  
     


A phase I/II trial of weekly nab‐paclitaxel for pretreated non‐small‐cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement
Authors:Daijiro Harada  Toshiyuki Kozuki  Naoyuki Nogami  Akihiro Bessho  Shinobu Hosokawa  Nobuaki Fukamatsu  Katsuyuki Hotta  Kadoaki Ohashi  Toshio Kubo  Hiroshige Yoshioka  Toshihide Yokoyama  Naoyuki Sone  Shoichi Kuyama  Kenichiro Kudo  Masayuki Yasugi  Nagio Takigawa  Isao Oze  Katsuyuki Kiura
Abstract:
Keywords:cytotoxic chemotherapy  nanoparticle albumin‐bound paclitaxel  non‐small cell lung cancer  pretreated NSCLC  wild‐type
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号